Journal of Cancer Therapy
Vol.7 No.7(2016), Paper ID 67892, 9
pages
DOI:10.4236/jct.2016.77049
Outcome of Combination Chemotherapy with Docetaxel, Estramustine Phosphate, and Carboplatin after Docetaxel and Prednisolone Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer
Ryuichi Ito, Shintaro Narita, Hiroshi Tsuruta, Kazuyuki Numakura, Atsushi Maeno, Mitsuru Saito, Takamitsu Inoue, Norihiko Tsuchiya, Shigeru Satoh, Tomonori Habuchi
Department of Urology, Akita University School of Medicine, Akita, Japan
Department of Urology, Akita University School of Medicine, Akita, Japan
Department of Urology, Akita University School of Medicine, Akita, Japan
Department of Urology, Akita University School of Medicine, Akita, Japan
Department of Urology, Akita University School of Medicine, Akita, Japan
Department of Urology, Akita University School of Medicine, Akita, Japan
Department of Urology, Akita University School of Medicine, Akita, Japan
Department of Urology, Akita University School of Medicine, Akita, Japan
Department of Urology, Akita University School of Medicine, Akita, Japan
Department of Urology, Akita University School of Medicine, Akita, Japan
Copyright © 2016 Ryuichi Ito, Shintaro Narita, Hiroshi Tsuruta, Kazuyuki Numakura, Atsushi Maeno, Mitsuru Saito, Takamitsu Inoue, Norihiko Tsuchiya, Shigeru Satoh, Tomonori Habuchi et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Ito, R. , Narita, S. , Tsuruta, H. , Numakura, K. , Maeno, A. , Saito, M. , Inoue, T. , Tsuchiya, N. , Satoh, S. and Habuchi, T. (2016) Outcome of Combination Chemotherapy with Docetaxel, Estramustine Phosphate, and Carboplatin after Docetaxel and Prednisolone Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer.
Journal of Cancer Therapy,
7, 471-479. doi:
10.4236/jct.2016.77049.